Clinical Research Directory
Browse clinical research sites, groups, and studies.
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Sponsor: GlaxoSmithKline
Summary
This is a prospective, real-world, single arm, global, multi-centre study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma with an eosinophilic phenotype (SA-EP).
Official title: A Prospective, Real-World, Interventional Study To Evaluate The Effect Of Mepolizumab On Achieving Clinical Remission In Participants With Severe Asthma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
336
Start Date
2024-03-20
Completion Date
2028-06-14
Last Updated
2025-08-01
Healthy Volunteers
No
Conditions
Interventions
Mepolizumab
Mepolizumab will be prescribed based on physician decision.
Spirometry
Lung function via spirometry will be collected.
Locations (65)
GSK Investigational Site
La Jolla, California, United States
GSK Investigational Site
Newport Beach, California, United States
GSK Investigational Site
Aurora, Colorado, United States
GSK Investigational Site
Colorado Springs, Colorado, United States
GSK Investigational Site
New Haven, Connecticut, United States
GSK Investigational Site
Homestead, Florida, United States
GSK Investigational Site
Jacksonville, Florida, United States
GSK Investigational Site
Miami, Florida, United States
GSK Investigational Site
Plantation, Florida, United States
GSK Investigational Site
Adairsville, Georgia, United States
GSK Investigational Site
Columbus, Georgia, United States
GSK Investigational Site
Lexington, Kentucky, United States
GSK Investigational Site
Owensboro, Kentucky, United States
GSK Investigational Site
New Orleans, Louisiana, United States
GSK Investigational Site
Glenn Dale, Maryland, United States
GSK Investigational Site
Towson, Maryland, United States
GSK Investigational Site
Ann Arbor, Michigan, United States
GSK Investigational Site
Rochester, Minnesota, United States
GSK Investigational Site
Henderson, Nevada, United States
GSK Investigational Site
Linwood, New Jersey, United States
GSK Investigational Site
Rochester, New York, United States
GSK Investigational Site
Schenectady, New York, United States
GSK Investigational Site
Philadelphia, Pennsylvania, United States
GSK Investigational Site
Philadelphia, Pennsylvania, United States
GSK Investigational Site
Union, South Carolina, United States
GSK Investigational Site
Cypress, Texas, United States
GSK Investigational Site
Kerrville, Texas, United States
GSK Investigational Site
McKinney, Texas, United States
GSK Investigational Site
Kortrijk, Belgium
GSK Investigational Site
Liège, Belgium
GSK Investigational Site
Calgary, Alberta, Canada
GSK Investigational Site
Calgary, Alberta, Canada
GSK Investigational Site
Winnipeg, Manitoba, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Brest, France
GSK Investigational Site
Cannes, France
GSK Investigational Site
Lille, France
GSK Investigational Site
Lyon, France
GSK Investigational Site
Strasbourg, France
GSK Investigational Site
Toulouse, France
GSK Investigational Site
Aachen, Germany
GSK Investigational Site
Bonn, Germany
GSK Investigational Site
Darmstadt, Germany
GSK Investigational Site
Frankfurt, Germany
GSK Investigational Site
Hohenstein-Ernsttal, Germany
GSK Investigational Site
Schleswig, Germany
GSK Investigational Site
Genova, Italy
GSK Investigational Site
Monserrato CA, Italy
GSK Investigational Site
Naples, Italy
GSK Investigational Site
Pieve Di Soligo TV, Italy
GSK Investigational Site
Roma, Italy
GSK Investigational Site
Roma, Italy
GSK Investigational Site
Rozzano, Italy
GSK Investigational Site
Verona, Italy
GSK Investigational Site
Gifu, Japan
GSK Investigational Site
Kagawa, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
?Od?, Poland
GSK Investigational Site
Gdansk, Poland
GSK Investigational Site
Lodz, Poland
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
Girona, Spain
GSK Investigational Site
Valencia, Spain